# Blood Pressure After PREeclampsia/HELLP by SELF Monitoring Study

Study · id `cardio:ct-nct03228082` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03228082](<https://clinicaltrials.gov/study/NCT03228082>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03228082

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT03228082. Randomized; no masking; primary purpose device feasibility. Start 2017-07-13 (actual); primary completion 2019-12-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose device feasibility
- Phase: Not applicable
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT03228082, source copy `cardio:ctgov-nct03228082-2020-10-06`, retrieved 2026-10-26)
- Started: 2017-07-13 (actual) (ClinicalTrials.gov record NCT03228082, source copy `cardio:ctgov-nct03228082-2020-10-06`, retrieved 2026-10-26)
- Primary completion: 2019-12-30 (actual) (ClinicalTrials.gov record NCT03228082, source copy `cardio:ctgov-nct03228082-2020-10-06`, retrieved 2026-10-26)
- Completion: 2019-12-30 (actual) (ClinicalTrials.gov record NCT03228082, source copy `cardio:ctgov-nct03228082-2020-10-06`, retrieved 2026-10-26)
- Countries: Germany; Netherlands (ClinicalTrials.gov record NCT03228082, source copy `cardio:ctgov-nct03228082-2020-10-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03228082-2020-10-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Blood Pressure After PREeclampsia/HELLP by SELF Monitoring Study
- Acronym: BP-PRESELF
- Condition: Preeclampsia
- Condition: Cardiovascular Risk Factor
- Condition: Cardiovascular Diseases
- Condition: Hypertension
- Intervention (Device): Home Blood Pressure Monitoring (HBPM)
- Lead sponsor: Radboud University Medical Center
- Lead sponsor class: OTHER
- Collaborator: Interreg
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Radboud University Medical Center (`cardio:org-radboud-university-medical-center`)

## Provenance

Content hash: 6026bd3cc3ec402921a4dd31b6cd450883595eaa3e6563b67f1a04e00d2be656
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
